Protective Effect of Baicalin Against Experimental Colitis via Suppression of Oxidant Stress and Apoptosis
Jun Yao1, Xu Cao2, Ru Zhang1, Ying‑xue Li1, Zheng‑lei Xu1, Ding‑guo Zhang1, Li‑sheng Wang1★, Jian‑yao Wang3★★ Corresponding author
- 1Departments of Gastroenterology, University of Medical Sciences, Shenzhen Municipal People’s Hospital, Shenzhen 518020, China.
- 2Internal Medicine-Neurology, Shenzhen genetic engineering Animal Center, Jinan University of Medical Sciences, Shenzhen Municipal People’s Hospital, Shenzhen 518020, China.
- 3Department of General Surgery, Shenzhen Children’s Hospital, Shenzhen 518026, Guangdong Province, China.
CORRESPONDENCE
Li‑sheng Wang
Departments of Gastroenterology, University of Medical Sciences, Shenzhen Municipal People’s Hospital, Shenzhen 518020, China.
Received: 07-06-2015; Revised: 27-06-2015.
Volume 12, Issue 47 · pp. 225–234 · PUBLISHED 14 July 2016 · DOI: 10.4103/0973-1296.186342
View on Pharmacogn. Mag. original site ↗
ABSTRACT
Background: Baicalin is a bioactive ingredient extracted from the root of Scutellariae radix, which is used to treat ulcerative colitis (UC). Objective: We investigated the activity of baicalin on lipopolysaccharide‑stimulated RAW264.7 cells and 2,4,6‑trinitrobenzene sulfonic acid‑induced rats, including the attenuation of oxidant stress and apoptosis. Materials and Methods: The severity of colitis was assessed by disease activity index. The activities of catalase (CAT), glutathione peroxidase (GSH‑PX), superoxide dismutase (SOD), and the content of malondialdehyde (MDA) were determined by their corresponding kits. The terminal deoxynucleotidyl transferase‑mediated dUTP nick end‑labeling (TUNEL) was performed to study whether experimental colitis was associated with intestinal epithelial cell (IEC) apoptosis and the effect of baicalin on IEC apoptosis. Western blot analysis and immunocytochemistry assay were applied to determine the protein expressions. The reactive oxygen species (ROS) level in the colon of UC rats treated with baicalin was determined by ROS assay kit. Results: Baicalin remarkably upregulated the activities of CAT, GSH‑PX, and SOD and decreased the content of MDA in a dose‑dependent manner in vitro and in vivo. The TUNEL‑positive cells in rats treated baicalin were remarkably reduced. Both Western blot analysis and immunocytochemistry assay indicated that baicalin significantly decreased the expressions of transforming growth factor beta‑1, Bax protein and upregulated the expression of Bcl‑2 protein. In addition, the expressions of total and cleaved caspase‑3, total and cleaved caspase‑9 protein, Fas, and FasL in vitro were downregulated by the treatment with baicalin. Baicalin of different doses reduced the generation of ROS in UC rats. Conclusion: Taken together, these evidences provide scientific basics for the application of baicalin in the treatment of UC and suggest that baicalin exerts its effect via suppression of oxidant stress and apoptosis.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Yao, J., Cao, X., Zhang, R., Li, Y., Xu, Z., Zhang, D., Wang, L., & Wang, J. (2016). Protective Effect of Baicalin Against Experimental Colitis via Suppression of Oxidant Stress and Apoptosis. Pharmacognosy Magazine, 12(47), 225–234. https://doi.org/10.4103/0973-1296.186342
